Shezad Malik Law Firm Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Articles Tagged with Heart Failure

Onglyza Heart Failure Injuries Lawsuits Centralized. Recently, the U.S. Judicial Panel on Multidistrict Litigation (JPML) has ordered that all filed federal Onglyza heart failure injuries lawsuits be consolidated and centralized as part of multidistrict litigation or MDL.

Onglyza Heart Failure Injuries

Onglyza Heart Failure Injuries. Onglyza and Kombiglyze linked to heart failure according to the FDA Warning

Type 2 diabetic patients who used Onglyza and developed heart problems allegedly caused by the diabetes drug will be consolidated in the U.S. District Court Eastern District of Kentucky, before U.S. District Judge Karen Caldwell.

Onglyza Heart Failure. Wrendell Chester, from Texas, recently filed a personal injury and product liability lawsuit, against Bristol-Myers Squibb and AstraZeneca, the manufacturers of the drug.

Onglyza Heart Failure Attorney

Onglyza and Kombiglyze linked to heart failure according to the FDA Warning

Chester claims that the companies failed to adequately warn patients and doctors about the risk of heart failure from side effects of Onglyza and failed to conduct proper research and testing.

Thoratec HeartMate II Left Ventrical Assist Device (LVAD) or a Left Ventrical Assist System (LVAS), is a mechanical heart pump that is used to continuously pump blood through the heart. It is a critical bridge device for patients with advanced heart failure who are awaiting a heart transplant.

Thoratec Heart Mate II LawyerEvery year, about 4,000 people are implanted with an LVAD, and about 75% receive the HeartMate II. Unfortunately it can form deadly blood clots, according to a recent medical report.

The implanted device caused 72 blood clots in 66 patients at three institutions, where 895 devices were implanted from 2004 through 2013, according to a study in the New England Journal of Medicine. The report pooled data from the Cleveland Clinic in Ohio, Washington University Barnes-Jewish Hospital in St. Louis, and Duke Medical University Center.

Contact Information